In addition, as the concentration of the added recombinant TIMP‐2 was increased from 5 ng/mL to 20 ng/mL, the 5‐Fu resistance of TIMP‐2 to CRC non‐resistant cell lines became more obvious (Figure 3A,B). This evidence concerns the gene TIMP2 and colorectal carcinoma.